Dab2IP GTPase Activating Protein Regulates Dendrite Development and Synapse Number in Cerebellum
DOC-2/DAB-2 interacting protein (Dab2IP) is a GTPase activating protein that binds to Disabled-1, a cytosolic adapter protein involved in Reelin signaling and brain development. Dab2IP regulates PI3K-AKT signaling and is associated with metastatic prostate cancer, abdominal aortic aneurysms and coro...
Saved in:
Published in | PloS one Vol. 8; no. 1; p. e53635 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
09.01.2013
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | DOC-2/DAB-2 interacting protein (Dab2IP) is a GTPase activating protein that binds to Disabled-1, a cytosolic adapter protein involved in Reelin signaling and brain development. Dab2IP regulates PI3K-AKT signaling and is associated with metastatic prostate cancer, abdominal aortic aneurysms and coronary heart disease. To date, the physiological function of Dab2IP in the nervous system, where it is highly expressed, is relatively unknown. In this study, we generated a mouse model with a targeted disruption of Dab2IP using a retrovirus gene trap strategy. Unlike reeler mice, Dab2IP knock-down mice did not exhibit severe ataxia or cerebellar hypoplasia. However, Dab2IP deficiency produced a number of cerebellar abnormalities such as a delay in the development of Purkinje cell (PC) dendrites, a decrease in the parallel fiber synaptic marker VGluT1, and an increase in the climbing fiber synaptic marker VGluT2. These findings demonstrate for the first time that Dab2IP plays an important role in dendrite development and regulates the number of synapses in the cerebellum. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore Maryland, United States of America Competing Interests: The authors have declared that no competing interests exist. Current address: Centre for Molecular Medicine and Therapeutics, Children and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada Conceived and designed the experiments: SQ S-HK RH. Performed the experiments: SQ SK. Analyzed the data: SQ S-HK DH MSL. Contributed reagents/materials/analysis tools: MSL DG DH RH. Wrote the paper: SQ S-KH MSL RH. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0053635 |